Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Paras Healthcare...

    Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-17T09:45:43+05:30  |  Updated On 16 Aug 2021 3:46 PM IST





    "We are investing Rs 500 crore to add 830 beds in 2019 across our three hospitals. This includes 232 beds in our Panchkula hospital which we have just opened," Paras Healthcare Managing Director Dharminder Nagar told.

    New Delhi: Established in 2006, Paras Healthcare aims to fill the specialized tertiary care gap in the under-served region. The firm seems to move forward with the objective as it has recently infused Rs 500 crore to add 830 beds in 2019, a top company official said Wednesday. The company has hospitals in Gurugram, Patna, Darbhanga and Panchkula.

    "We are investing Rs 500 crore to add 830 beds in 2019 across our three hospitals. This includes 232 beds in our Panchkula hospital which we have just opened," Paras Healthcare Managing Director Dharminder Nagar told.

    The multi-speciality hospital in Panchkula is a part of the company's expansion plan for the year, he added.

    Paras Hospitals, Panchkula, the new 232 bed hospital, is the first in the region to provide comprehensive cancer care facilities ranging from chemotherapy, surgical oncology, radiation therapy and nuclear medicine. It is the first hospital in Panchkula to have a PET CT Scan machine, the latest technology which aids in cancer detection.

    The company will also be opening a hospital in Ranchi with 350 beds during the year and will be adding 250 beds in another hospital, Nagar said without disclosing the location of the hospital.


    Read Also: Paras Healthcare raises Rs 275 crore from Creador



    The hospital in Ranchi is being set up in partnership with Heavy Engineering Corporation (HEC), he added.

    When asked how the company is funding the expansion, Nagar said: "This is mainly through equity which we have raised. The company had raised USD 42 million (around Rs 275 crore) in July 2017 from private equity firm Creador. The rest would be through debt."

    The company follows an asset-light model and its focus has always been to serve the middle class and to manage the quality and be cost-effective, he added.

    Also Read: VPS Healthcare sets aside Rs 1,000 crore for investing in Indian Hospital Space




    CreadorDharminder NagarGurgaonGurugramhealthcare in IndiaHeavy Engineering CorporationHEChospital newsindian hospital newsinvestingmulti specialty hospital panchkulaNew DelhiPanchkula hospitalparas health carepartnershipRanchi
    Source : With input

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok